The Mechanisms and Applications of Mentalized-Based Treatment for Adolescents with Borderline Personality Disorder
DOI:
https://doi.org/10.61173/zn7ax536Keywords:
Borderline personality disorder, adolescent, mentalized-based treatmentAbstract
Borderline personality disorder (BPD) is a mental illness that often causes depression, interpersonal disturbances, and strong self-harm or even suicidal tendencies. The impact of an individual’s early experiences significantly contributes to BPD. This disease is widespread in adolescents as the prevalence of BPD in adolescents has been on an upward trend
over the past decades. Mentalization-based treatment (MBT) is one of the psychotherapies comprised of individual treatment and small closed-group treatment to provide a sense of safety. MBT has been considered one of the most effective treatments through the improvement of an individual’s mentalization, strengthening of self-recognition, reducing the extent of depression, and decreasing self-harm. However, the relevant clinical research based on the treatment leaves a gap. This paper aims to inform on the mechanism and theories of MBT as the primary treatment for BPD, including the unique characteristics of MBT that enhance the therapy process, which mainly targets adolescents. In future research, clinical trials of adolescent BPD with MBT treatment methods are required to optimize and improve the MBT. MBT can become one of the primary directions for psychologists and outpatient therapists.
References
[1] Bourvis N., Cohen D., Benarous X. Therapeutic and Preventive Interventions in Adolescents with Borderline Personality Disorder: Recent Findings, Current Challenges, and Future Directions. Journal of Clinical Medicine, 2023, 12(20): 6668.
[2] Fonagy P., Luyten P. A developmental, mentalization-based approach to the understanding and treatment of borderline personality disorder. Development and Psychopathology, 2009, 21(4): 1355-1381.
[3] Ørts Clemmensen L.M., Olrik Wallenstein Jensen S., Zanarini M.C., Skadhede S., Munk-Jørgensen P. Changes in treated incidence of borderline personality disorder in denmark: 1970- 2009. The Canadian Journal of Psychiatry, 2013 Sep;58(9):522- 528.
[4] Bohus M., Stoffers-Winterling J., Sharp C., Krause-Utz A., Schmahl C., Lieb K. Borderline personality disorder. Lancet, 2021, 398(10310): 1528-1540.
[5] Simonsen S., Hestbæk E., Juul S. Adapting Short-Term Mentalization-Based Therapy to ICD-11 Personality Disorder in Adolescents. Children (Basel), 2023, 10(1): 93.
[6] Rossouw, T.I., Fonagy, P. Mentalization-Based Treatment for Self-Harm in Adolescents: A Randomized Controlled Trial. Journal of the American Chemical Society.
[7] Daubney M., Bateman A. Mentalization-based therapy (MBT): an overview. Australasian Psychiatry. 2015, 23(2): 132- 135.
[8] Bateman A, Fonagy P. Mentalization-Based Treatment. Psychoanalytic Inquiry, 2013, 33(6): 595-613.
[9] Mendez-Miller M., Naccarato J., Radico J.A. Borderline Personality Disorder. American Family Physician, 2022, 105(2): 156-161.
[10] Southward M.W., Cheavens J.S. Identifying core deficits in a dimensional model of borderline personality disorder features: a network analysis. Clinical Psychological Science, 2018, 6(5): 685-703.
[11] Preti E., Richetin J., Poggi A., Fertuck E. A Model of Trust Processes in Borderline Personality Disorder: A Systematic Review. Current Psychiatry Reports, 2023, 25(11): 555-567.
[12] Stoffers-Winterling J.M., Storebø O.J., Simonsen E., Sedoc Jørgensen M., Pereira Ribeiro J., Kongerslev MT., Lieb K. Perspectives on dialectical behavior therapy and mentalizationbased therapy for borderline personality disorder: same, different, complementary? Psychology Research and Behavior Management, 2022, 15: 3179-3189.
[13] Schulz S.C., Zanarini M.C., Bateman A., Bohus M., Detke H.C., Trzaskoma Q., Tanaka Y,. Lin D., Deberdt W., Corya S. Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebocontrolled study. The British Journal of Psychiatry, 2008, 193(6): 485-92.
[14] Rossouw T.I., Fonagy P. Mentalization-based treatment for self-harm in adolescents: A randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 2012, 51: 1304-1313.
[15] Simonsen S, Hestbæk E, Juul S. Adapting Short-Term Mentalization-Based Therapy to ICD-11 Personality Disorder in Adolescents. Children (Basel), 2023, 10(1): 93.
[16] Laurenssen E.M., Hutsebaut J., Feenstra D.J., Bales D.L., Noom M.J., Busschbach J.J., Verheul R., Luyten P. Feasibility of mentalization-based treatment for adolescents with borderline symptoms: A pilot study. Psychotherapy, 2014, 51: 159-166.
[17] Mehlum L., Tørmoen A.J., Ramberg M., Haga E., Diep L.M., Laberg S., Larsson B.S., Stanley B.H., Miller A.L., Sund A.M., Grøholt B. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: a randomized trial. Journal of the American Academy of Child & Adolescent Psychiatry, 2014, 53(10): 1082-1091.
[18] Beck E., Bo S., Gondan M., Poulsen S., Pedersen L., Pedersen J., Simonsen E. Mentalization-based treatment in groups for adolescents with borderline personality disorder (BPD) or subthreshold BPD versus treatment as usual (M-GAB): study protocol for a randomized controlled trial. Trials, 2016, 17(1): 314.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
